Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $8.16, but opened at $7.93. Cytek Biosciences shares last traded at $8.09, with a volume of 30,759 shares traded. Analyst Upgrades and Downgrades Several analysts have recently weighed in on […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CFO Patrik Jeanmonod sold 3,000 shares of the business’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $9.50, for a total value of $28,500.00. Following the completion of the transaction, the chief financial officer now directly owns 93,400 […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CFO Patrik Jeanmonod sold 3,000 shares of Cytek Biosciences stock in a transaction dated Friday, November 24th. The shares were sold at an average price of $6.94, for a total value of $20,820.00. Following the completion of the transaction, the chief financial officer now owns 96,400 shares […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CFO Patrik Jeanmonod sold 3,000 shares of the business’s stock in a transaction on Friday, November 24th. The shares were sold at an average price of $6.94, for a total transaction of $20,820.00. Following the transaction, the chief financial officer now directly owns 96,400 shares in the […]
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker […]